Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

53.95
Delayed Data
As of Dec 14
 -0.03 / -0.06%
Today’s Change
25.92
Today|||52-Week Range
54.98
+61.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues10.4M9.0M7.5M75.9M
 
 
 
 
 
Depreciation And Amortization493.0K528.0K552.0K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses17.0M17.9M20.1M21.6M
 
 
 
 
 
Research And Development12.5M13.0M15.4M16.5M
 
 
 
 
 
Total Operating Expenses17.5M18.5M20.6M21.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.0M-9.5M-13.1M54.3M
 
 
 
 
 
Extraordinary Charge-13.0K-15.0K-17.0K--
 
 
 
 
Interest Expense On Debt12.0K8.0K11.0K--
 
 
 
 
Other Expenses0.000.000.00660.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.5M-9.0M-12.5M55.0M
 
 
 
 
 
Income Taxes-1.5M-3.6M-4.1M-18.4M
 
 
 
 
 
Net Income-5.0M-5.4M-8.4M36.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.0M19.0M19.1M19.1M
 
 
 
 
 
Shares To Calculate EPS Diluted19.0M19.0M19.1M19.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.26-$0.28-$0.44$1.86
 
 
 
 
 
EPS Diluted-$0.26-$0.28-$0.44$1.86